Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Immunological Methods|August 26, 1993
A rapid and highly selective approach to cell separations using an immunomagnetic colloidJ P Hancock, J T KemsheadInternational Journal of Cancer|January 2, 1991
Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C)L S Lashford, J P Hancock, J T KemsheadExperimental Cell Research|January 1, 1989
Cellular senescence involves stochastic processes causing loss of expression of differentiated function genes: visualization by in situ hybridization for steroid 17 alpha-hydroxylase in bovine adrenocortical cellsR F Ryan, J P Hancock, J J McDonald, et al.Journal of Immunological Methods|September 15, 1999
The use of Teflon cell culture bags to expand functionally active CD8+ cytotoxic T lymphocytesR J Garland, S S Kaneria, J P Hancock, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1987
Loss of expression of a differentiated function gene, steroid 17 alpha-hydroxylase, as adrenocortical cells senescence in cultureP J Hornsby, J P Hancock, T P Vo, et al.Scandinavian Journal of Immunology|February 14, 2002
Human CD8+ CTL recognition and in vitro lysis of herpes simplex virus-infected cells by a non-MHC restricted mechanismR J Garland, N El-Shanti, S E West, et al.British Journal of Haematology|February 5, 1998
Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemiaN J Goulden, C J Knechtli, R J Garland, et al.British Journal of Haematology|December 31, 1997
Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantationJ P Hancock, M F Burgess, N J Goulden, et al.British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.Pageof 1